| |
Group A
|
Group B
|
p
|
|---|
|
Age, years
|
47,70 ± 13,36
|
53,53 ± 10,89
|
0,026
|
|
Sex, female (%)
|
10/33 (30%)
|
34/58 (59%)
|
0,008
|
|
BSA m2
|
1,8 ± 0,16
|
1,73 ± 0,13
|
0,022
|
|
Effort Angina
|
28/33 (85%)
|
33/58 (56%)
|
0,006
|
|
Effortless Angina
|
9/33 (27%)
|
35/58 (57%)
|
0,002
|
|
Duration of symptoms before cath. (months)
|
15 ± 10
|
46 ± 40
|
0,000
|
|
Time of FLW (months)
|
36,4 ± 17,9
|
39,1 ± 19,5
|
0,55
|
|
Events in FLW
|
6/33 (18%)
|
8/56 (14%)
|
0,31
|
|
ACS in FLW
|
1/33 (3%)
|
7/56 (13%)
|
0,24
|
|
β Bloq.
|
7/33 (21%)
|
11/58 (19%)
|
0,798
|
|
CCB
|
4/33 (12%)
|
7/58 (12%)
|
0,666
|
|
Nitrates
|
16/33 (48%)
|
31/58 (53%)
|
0,769
|
|
IECA/ARAII
|
5/33 (15%)
|
7/58 (12%)
|
0,680
|
|
Diuretics
|
2/33 (6%)
|
5/58 (9%)
|
0,663
|
|
β Bloq. FLW
|
20/33 (60%)
|
17/56 (30%)
|
0,003
|
|
CCB FLW
|
4/33(12%)
|
19/56 (34%)
|
0,530
|
|
Nitrates FLW
|
9/33 (27%)
|
33/56 (59%)
|
0,006
|
|
IECA/ARAII FLW
|
9/33 (27%)
|
8/56 (14%)
|
0,068
|
|
Diuretics FLW
|
4/33(12%)
|
4/56 (7%)
|
0,403
|
- BSA – body surface area; ACS – Acute coronary Syndrome; CCB – Calcium chanell blockers; FLW – follow-up
